Data / Form D filings / VEDANTA BIOSCIENCES, INC.
VEDANTA BIOSCIENCES, INC.: Form D filings
VEDANTA BIOSCIENCES, INC., a biotechnology company in Cambridge, MA, filed 7 Form D notices with the SEC between 2019 and 2024. The latest, on August 5, 2024, reports $118.5 million sold of a $118.5 million offering to 25 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 19 BLACKSTONE STREET, Cambridge, MA, 02139
- Phone
- (857) 706-1427
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1677878
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Aug 5, 2024 | Amendment | $118,500,000 | $118,500,000 | 25 | Mar 1, 2023 | sec.gov | |
| May 2, 2023 | New notice | $106,500,000 | $106,500,000 | 22 | Mar 1, 2023 | sec.gov | |
| Aug 13, 2021 | New notice | $74,999,998 | $68,406,915 | $6,593,083 | 18 | Jul 16, 2021 | sec.gov |
| Sep 19, 2019 | New notice | $16,570,052 | $7,999,939 | $8,570,113 | 4 | Sep 11, 2019 | sec.gov |
| May 8, 2019 | Amendment | $49,999,988 | $45,394,519 | $4,605,469 | 13 | Dec 21, 2018 | sec.gov |
| Mar 28, 2019 | Amendment | $49,999,988 | $39,894,283 | $10,105,705 | 11 | Dec 21, 2018 | sec.gov |
| Feb 5, 2019 | New notice | $49,999,988 | $26,726,683 | $23,273,305 | 8 | Dec 21, 2018 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| John LaMattina | Director | |
| Charles Sherwood | Director | |
| Susan Dillon | Director | |
| Martin Heidecker | Director | |
| Neil Tiwari | Director | |
| Curt LaBelle | Director | |
| Daniel Couto | Executive Officer | |
| Bernat Olle | Executive Officer, Director | |
| Mark Mullikin | Executive Officer | |
| Bennett Shapiro | Director | |
| Troy Ignelzi | Director | |
| Jeffrey Silber | Executive Officer |
Other biotechnology companies in Massachusetts that filed recently
- Tru Singular Health, Inc. $1 million · Oct 30, 2026
- 511 Therapeutics, Inc. $500,000 · Oct 30, 2026
- Elucid Bioimaging Inc. $56.2 million · Oct 27, 2026
- OrthoIQ, Inc. $1.1 million · Oct 23, 2026
- LeanBio Therapeutics, Inc. offering · Oct 22, 2026
- Quiver Holdings Inc. $3 million · Oct 21, 2026
Every Form D from the week of Aug 5, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what VEDANTA BIOSCIENCES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.